CirChem AB Net Assets
CirChem AB net assets. Based on the latest financial reports, CirChem AB (CIRCHE) has net assets worth Skr38.21 Million SEK (≈ $4.11 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr64.35 Million ≈ $6.93 Million USD) and total liabilities (Skr26.15 Million ≈ $2.81 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See CirChem AB (CIRCHE) net asset quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr38.21 Million |
| % of Total Assets | 59.37% |
| Annual Growth Rate | 31.67% |
| 5-Year Change | 68.08% |
| 10-Year Change | N/A |
| Growth Volatility | 96.58 |
Net Assets of CirChem AB (2017–2025)
Net assets of CirChem AB from 2017 to 2025. This chart illustrates how CirChem AB's net assets have evolved over time, based on quarterly financial data. Also explore CIRCHE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Net Assets for CirChem AB (2017–2025)
The table below shows the annual net assets of CirChem AB from 2017 to 2025. For live market cap and overall valuation, see CIRCHE stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr44.33 Million ≈ $4.77 Million |
-2.97% |
| 2024-12-31 | Skr45.68 Million ≈ $4.92 Million |
+30.14% |
| 2023-12-31 | Skr35.10 Million ≈ $3.78 Million |
+39.70% |
| 2022-12-31 | Skr25.13 Million ≈ $2.70 Million |
-4.72% |
| 2021-12-31 | Skr26.37 Million ≈ $2.84 Million |
-40.77% |
| 2020-12-31 | Skr44.52 Million ≈ $4.79 Million |
+36.86% |
| 2019-12-31 | Skr32.53 Million ≈ $3.50 Million |
+294.18% |
| 2018-12-31 | Skr8.25 Million ≈ $888.18K |
+68.16% |
| 2017-12-31 | Skr4.91 Million ≈ $528.17K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CirChem AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 349.4% over the analyzed period, potentially due to dividend distributions or operating losses.
CirChem AB Net Assets Breakdown (December 2025)
CirChem AB net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr2.51 Million | 5.67% |
| Other Components | Skr53.87 Million | 121.51% |
| Total Equity | Skr44.33 Million | 100.00% |
CirChem AB Competitors by Market Cap
The table below lists competitors of CirChem AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
$2.07 Million |
|
Entreparticuli
PA:ALENT
|
$2.07 Million |
|
VivoSim Labs, Inc.
NASDAQ:VIVS
|
$2.07 Million |
|
Aruma Resources Ltd
AU:AAJ
|
$2.08 Million |
|
Chakana Copper Corp
V:PERU
|
$2.06 Million |
|
Invion Ltd
AU:IVX
|
$2.06 Million |
|
Fintel PLC
LSE:FNTL
|
$2.06 Million |
|
Sri Havisha Hospitality and Infrastructure Limited
NSE:HAVISHA
|
$2.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CirChem AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 45,684,000 to 44,328,000, a change of -1,356,000 (-3.0%).
- Net loss of 12,050,000 reduced equity.
- New share issuances of 13,402,000 increased equity.
- Other factors decreased equity by 2,708,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-12.05 Million | -27.18% |
| Share Issuances | Skr13.40 Million | +30.23% |
| Other Changes | Skr-2.71 Million | -6.11% |
| Total Change | Skr- | -2.97% |
Book Value vs Market Value Analysis
This analysis compares CirChem AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.39x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.43x to 0.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Skr0.33 | Skr0.47 | x |
| 2018-12-31 | Skr0.55 | Skr0.47 | x |
| 2019-12-31 | Skr2.17 | Skr0.47 | x |
| 2020-12-31 | Skr2.97 | Skr0.47 | x |
| 2021-12-31 | Skr1.76 | Skr0.47 | x |
| 2022-12-31 | Skr1.31 | Skr0.47 | x |
| 2023-12-31 | Skr1.22 | Skr0.47 | x |
| 2024-12-31 | Skr1.51 | Skr0.47 | x |
| 2025-12-31 | Skr1.21 | Skr0.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CirChem AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -27.18%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -121.00%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.57x
- Recent ROE (-27.18%) is above the historical average (-35.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -10.72% | 0.00% | 0.00x | 1.70x | Skr-1.02 Million |
| 2018 | -14.71% | -723.78% | 0.01x | 2.63x | Skr-2.04 Million |
| 2019 | -14.30% | -24785.10% | 0.00x | 1.37x | Skr-7.91 Million |
| 2020 | -22.55% | -13714.19% | 0.00x | 1.28x | Skr-14.49 Million |
| 2021 | -73.87% | -22771.74% | 0.00x | 1.98x | Skr-22.12 Million |
| 2022 | -101.48% | -4317.37% | 0.01x | 2.00x | Skr-28.01 Million |
| 2023 | -48.83% | -298.36% | 0.10x | 1.68x | Skr-20.65 Million |
| 2024 | -2.34% | -5.18% | 0.34x | 1.34x | Skr-5.64 Million |
| 2025 | -27.18% | -121.00% | 0.14x | 1.57x | Skr-16.48 Million |
Industry Comparison
This section compares CirChem AB's net assets metrics with peer companies in the Waste Management industry.
Industry Context
- Industry: Waste Management
- Average net assets among peers: $154,155,743
- Average return on equity (ROE) among peers: -18.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CirChem AB (CIRCHE) | Skr38.21 Million | -10.72% | 0.68x | $2.06 Million |
| Axolot Solutions Holding AB (AXOLOT) | $28.22 Million | -58.16% | 0.05x | $7.60 Million |
| Kollect on Demand Holding Ab (KOLL) | $-3.21 Million | 0.00% | 0.00x | $719.15K |
| Scandinavian Enviro Systems AB (SES) | $24.99 Million | -25.06% | 2.91x | $13.68 Million |
| Studsvik AB (SVIK) | $566.63 Million | 10.79% | 1.09x | $183.08 Million |
About CirChem AB
CirChem AB (publ), an environmental technology company, engages in the solvent recycling business in Sweden. It collects, filters, and purifies industrial solvents for reuse. The company is also involved in the production of chemical products, such as washer fluids and hand sanitizers. CirChem AB (publ) was incorporated in 2013 and is headquartered in Vargön, Sweden.